ArticleJIMD reports2021

Enzyme replacement therapy interruption in mucopolysaccharidosis type IVA patients and its impact in different clinical outcomes.

Juan Politei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.